Ian M. Baird

569 total citations
18 papers, 409 citations indexed

About

Ian M. Baird is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Ian M. Baird has authored 18 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Infectious Diseases and 4 papers in Surgery. Recurrent topics in Ian M. Baird's work include Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Pneumonia and Respiratory Infections (3 papers). Ian M. Baird is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Pneumonia and Respiratory Infections (3 papers). Ian M. Baird collaborates with scholars based in United States, United Kingdom and Puerto Rico. Ian M. Baird's co-authors include Chatrchai Watanakunakorn, Joseph F. Plouffe, Guy W. Amsden, Stuart H. Simon, Robert Fekety, Gary D. Rifkin, O G Dodge, Thomas M. File, D. H. Batts and James B. Kahn and has published in prestigious journals such as Clinical Infectious Diseases, Gut and CHEST Journal.

In The Last Decade

Ian M. Baird

18 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian M. Baird United States 10 235 166 81 65 62 18 409
H.A. Verbrugh Netherlands 10 183 0.8× 165 1.0× 95 1.2× 63 1.0× 52 0.8× 20 458
H. Bradford Hawley United States 11 178 0.8× 172 1.0× 136 1.7× 94 1.4× 102 1.6× 26 538
G J Malanoski United States 6 152 0.6× 196 1.2× 56 0.7× 128 2.0× 51 0.8× 8 389
W. John Spicer Australia 13 107 0.5× 145 0.9× 112 1.4× 63 1.0× 70 1.1× 34 469
Boris E. Reisberg United States 9 168 0.7× 171 1.0× 37 0.5× 47 0.7× 23 0.4× 11 318
C. H. Teoh-Chan Hong Kong 12 117 0.5× 87 0.5× 85 1.0× 37 0.6× 57 0.9× 21 497
Gary R. Kravitz United States 10 137 0.6× 182 1.1× 67 0.8× 103 1.6× 25 0.4× 14 434
M. E. García-Leoni Spain 6 317 1.3× 161 1.0× 54 0.7× 34 0.5× 37 0.6× 6 393
Rolf Maller Sweden 10 197 0.8× 53 0.3× 112 1.4× 32 0.5× 76 1.2× 19 412
A. Frémaux France 13 413 1.8× 123 0.7× 145 1.8× 34 0.5× 72 1.2× 32 506

Countries citing papers authored by Ian M. Baird

Since Specialization
Citations

This map shows the geographic impact of Ian M. Baird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian M. Baird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian M. Baird more than expected).

Fields of papers citing papers by Ian M. Baird

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian M. Baird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian M. Baird. The network helps show where Ian M. Baird may publish in the future.

Co-authorship network of co-authors of Ian M. Baird

This figure shows the co-authorship network connecting the top 25 collaborators of Ian M. Baird. A scholar is included among the top collaborators of Ian M. Baird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian M. Baird. Ian M. Baird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Elion, Richard, et al.. (1999). An open-label trial of stavudine, lamivudine and efavirenz in the treatment of HIV-positive, treatment-naive patients, and implications for clinical practice.. PubMed. 4 Suppl 3. 89–91. 1 indexed citations
3.
Gordon, Dan, Ian M. Baird, Rabih O. Darouiche, et al.. (1997). Liposomal nystatin (LNY) vs. amphotericin B (AMB) for Candidemia in non-neutropenic patients: A historical comparison. Clinical Infectious Diseases. 25(2). 382. 2 indexed citations
4.
Plouffe, Joseph F., et al.. (1996). Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization. Pneumonia Study Group. Antimicrobial Agents and Chemotherapy. 40(5). 1175–1179. 54 indexed citations
5.
Yangco, Bienvenido G., et al.. (1987). Comparative efficacy and safety of ceftizoxime, cefotaxime and latamoxef in the treatment of bacterial pneumonia in high risk patients. Journal of Antimicrobial Chemotherapy. 19(2). 239–248. 7 indexed citations
6.
File, Thomas M., James S. Tan, William G. Gardner, & Ian M. Baird. (1983). Cefoperazone versus cefamandole in the treatment of acute bacterial lower respiratory tract infections. Journal of Antimicrobial Chemotherapy. 11(1). 75–82. 6 indexed citations
7.
8.
File, Thomas M., et al.. (1982). Evaluation of cefoperazone in the therapy of urinary tract infections. Journal of Antimicrobial Chemotherapy. 9(3). 223–230. 2 indexed citations
9.
Myers, Joseph P. & Ian M. Baird. (1981). Case Report Tularemia in Ohio: Report of Two Cases and Clinical Review. The American Journal of the Medical Sciences. 282(3). 148–152. 2 indexed citations
10.
Batts, D. H., et al.. (1981). Treatment of Clostridium difficile colitis and diarrhea with vancomycin. The American Journal of Medicine. 71(5). 815–822. 60 indexed citations
11.
Williams, Michael E., et al.. (1980). Case Report Legionnaires’ disease with acute renal failure. The American Journal of the Medical Sciences. 279(3). 177–183. 20 indexed citations
12.
Watanakunakorn, Chatrchai & Ian M. Baird. (1977). Staphylococcus aureus bacteremia and endocarditis associated with a removable infected intravenous device. The American Journal of Medicine. 63(2). 253–256. 75 indexed citations
13.
Watanakunakorn, Chatrchai & Ian M. Baird. (1977). Prognostic factors in Staphylococcus aureus endocarditis and results of therapy with a penicillin and gentamicin. The American Journal of the Medical Sciences. 273(2). 133–140. 73 indexed citations
14.
Baird, Ian M., et al.. (1976). Nosocomial Infection with Gentamicin-Carbenicillin-Resistant Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 10(4). 626–629. 12 indexed citations
15.
Baird, Ian M., Robert Walters, & David Sutton. (1974). Absorption of Slow-release Iron and Effects of Ascorbic Acid in Normal Subjects and after Partial Gastrectomy. BMJ. 4(5943). 505–508. 10 indexed citations
16.
Baird, Ian M. & David Sutton. (1972). Blood loss after partial gastrectomy. Gut. 13(8). 634–637. 2 indexed citations
17.
Baird, Ian M., et al.. (1959). Cushingoid Reaction to Triamcinolone. BMJ. 1(5137). 1586–1587. 2 indexed citations
18.
Baird, Ian M. & O G Dodge. (1957). JEJUNAL BIOPSY AFFER PARTIAL GASTRECTOMY. QJM. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H.A. Verbrugh Breakdown of academic impact, for papers by H. Bradford Hawley Breakdown of academic impact, for papers by G J Malanoski Breakdown of academic impact, for papers by W. John Spicer Breakdown of academic impact, for papers by Boris E. Reisberg Breakdown of academic impact, for papers by C. H. Teoh-Chan Breakdown of academic impact, for papers by Gary R. Kravitz Breakdown of academic impact, for papers by M. E. García-Leoni Breakdown of academic impact, for papers by Rolf Maller Breakdown of academic impact, for papers by A. Frémaux
Rankless by CCL
2026